Uribegro S 50mg/5mg Tablet ER is a combination of two medicines used in the treatment of the symptoms of an overactive bladder. It relieves urinary symptoms like frequent urination, urgent need to urinate and inability to control urination.

Uribegro S 50mg/5mg Tablet ER is advised to be taken in the dose and duration as prescribed by your doctor. It may be taken with or without food, preferably at the same time each day. You should not stop taking the medicine without consulting the doctor as it may lead to the worsening of your symptoms. The course of the treatment should be completed for better efficacy of the medicine.

Some of the common side effects of this medicine are hypertension (high blood pressure), nasopharyngitis (inflammation of the throat and nasal passages), urinary tract infection, and headache. If any of the side effects bother you or persist, consult the doctor without delay.

Before receiving the treatment, inform your doctor if you are on any medication for any other health condition. If you are pregnant or breastfeeding, tell your doctor prior to the treatment. People with liver or kidney disease must be cautious while receiving the prescription and they must receive regular follow-ups as per the doctor’s advice.

Uses of Uribegro S Tablet ER

Overactive bladder (OAB) symptoms

Benefits of Uribegro S Tablet ER

In Overactive bladder (OAB) symptoms

Uribegro S 50mg/5mg Tablet ER helps to treat uncontrollable contractions (spasms) of the bladder muscles that cause frequent urination, urgent need to urinate, and inability to control passing of urine. It also relieves painful, or frequent urination and reduces urgency to urinate that may occur with some infections of the urinary tract. This way it helps manage the overactive bladder symptoms efficiently.

Side effects of Uribegro S Tablet ER

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them

Common side effects of Uribegro S

High blood pressure
Nasopharyngitis (inflammation of the throat and nasal passages)
Urinary tract infection
Headache
Dryness in mouth
Constipation
Increased heart rate
Blurred vision

How to use Uribegro S Tablet ER

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Uribegro S 50mg/5mg Tablet ER may be taken with or without food, but it is better to take it at a fixed time.

How Uribegro S Tablet ER works

Uribegro S 50mg/5mg Tablet ER is a combination of two medicines: Mirabegron and Solifenacin. Mirabegron is a beta 3-receptor agonist. It works by activating the receptor in the bladder, causing the bladder muscles to relax. Solifenacin is an antimuscarinic. It also works by relaxing muscles of the urinary bladder. In this way, it works to prevent frequent, urgent, or uncontrolled urge of urination.

Safety advice

Alcohol

CAUTION

Caution is advised when consuming alcohol with Uribegro S 50mg/5mg Tablet ER. Please consult your doctor.

Pregnancy

CONSULT YOUR DOCTOR

Information regarding the use of Uribegro S 50mg/5mg Tablet ER during pregnancy is not available. Please consult your doctor.

Breast feeding

CONSULT YOUR DOCTOR

Information regarding the use of Uribegro S 50mg/5mg Tablet ER during breastfeeding is not available. Please consult your doctor.

Driving

CONSULT YOUR DOCTOR

It is not known whether Uribegro S 50mg/5mg Tablet ER alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react.

Kidney

CONSULT YOUR DOCTOR

There is limited information available on the use of Uribegro S 50mg/5mg Tablet ER in patients with kidney disease. Please consult your doctor.

Liver

CONSULT YOUR DOCTOR

There is limited information available on the use of Uribegro S 50mg/5mg Tablet ER in patients with liver disease. Please consult your doctor.

All substitutes

For informational purposes only. Consult a doctor before taking any medicines.

Uribegro S 50mg/5mg Tablet ER

₹48.0/Tablet ER

Mirago S 50 Tablet ER

Sun Pharmaceutical Industries Ltd

₹54.8/tablet er

14% costlier

Ambigron S 50 Tablet ER

Wonne International

₹52.7/tablet er

10% costlier

Begroease-S 50 Tablet ER

Leeford Healthcare Ltd

₹48/tablet er

same price

Urihold S 50 Tablet ER

Aristo Pharmaceuticals Pvt Ltd

₹24.7/tablet er

49% cheaper

Mirakem S 50mg/5mg Tablet ER

Alkem Laboratories Ltd

₹52.5/tablet er

9% costlier

View all substitutes

Quick tips

Uribegro S 50mg/5mg Tablet ER helps you to have better control over your urination.
It may raise your blood pressure. Monitor your blood pressure regularly.
Try to keep your regular appointments with your doctor. This is so your doctor can check on your progress and review your treatment.
Avoid caffeine (tea, coffee, cola, etc.) as it is a natural diuretic (increased urine production) and will make your symptoms worse.
Avoid drinking too much water before going to bed as it will increase your urge to go to the toilet and thus disturb your sleep.

Fact Box

Habit Forming

Therapeutic Class

UROLOGY

Patient concerns

Urine leakage, overactive bladder

Dr. Deepak Kumar Soni

Ayurveda

Hi kindly share details history & reports

Overactive bladder having frequent urination. Cannot control urge of urine.

Dr. Deepak Kumar Soni

Ayurveda

https://goo.gl/forms/5QhDt8ZurRhhcjvD2 Kindly fill the health information so that I can advice best products to you thanks

Related lab tests

Urine Routine & Microscopy

Want to share the information?

Disclaimer:

Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.

References

Brown JH, Brandl K, Wess J. Muscarinic Receptor Agonists and Antagonists. In: Brunton LL, Hilal-Dandan R, Knollmann BC (Editors). Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 13th ed. New York, NY: McGraw-Hill Education; 2018. pp. 149-161.
Pappano AJ. Cholinoceptor-Blocking Drugs. In: Katzung BG, Masters SB, Trevor AJ (Editors). Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 113-126.

Marketer details

Name: Tas Med India Pvt Ltd

Address: Plot No. 45, N.T.M., Sector -26, Chandigarh

Country of origin: India

The list of available options shown with the same composition has been prepared upon the advice of registered medical practitioners, pharmacists affiliated with TATA 1MG. TATA 1MG does not promote any pharmaceutical product of any particular company, and all recommendations are based on the medical opinion, advisories from specialist medical and pharmaceutical professionals.